XML 40 R12.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Note 6 - Investments in Marketable Securities
3 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
Note
6
- Investments in Marketable Securities
 
All investments are classified as “Current assets” because they are available for sale at any time. These “available-for-sale” marketable securities are stated at fair value. The Company uses quoted prices in active markets for identical assets (consistent with the Level
1
definition in the fair value hierarchy) to measure the fair value of its investments on a recurring basis pursuant to ASC
820,
Fair Value Measurement
.
 
As of
December 31, 2019,
there were net accumulated unrealized gains of
$160,223,000
with these investments. With the adoption of ASU
No.
2016
-
01,
Subtopic
825
-
10
in the prior fiscal year, the Company recorded and included in its net income the net unrealized gains on investments of
$19,531,000
for the
three
months ended
December 31, 2019
as compared with a net unrealized losses on investments of
$28,640,000
in the prior year period. At
September 30, 2019,
there were net accumulated unrealized gains of
$140,692,000
recorded in the accompanying Consolidated Balance Sheets. Most of the unrealized gains were in the common stocks of
three
U.S. financial institutions and
one
foreign manufacturer.
 
Investments in marketable securities as of
December 31, 2019
and
September 30, 2019
are summarized below.
 
 
     
Investments in Marketable Securities
 
       
   
December 31, 2019
   
September 30, 2019
 
   
 
Aggregate
fair value
   
 
Adjusted
cost basis
   
Pretax net unrealized
gains
   
 
Aggregate
fair value
   
Amortized/
Adjusted
cost basis
   
Pretax
unrealized
gains
 
Marketable securities
                                               
Common stocks
  $
214,112,000
    $
53,889,000
    $
160,223,000
    $
194,581,000
    $
53,889,000
    $
140,692,000